Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors

Clinical trial NCT03507998 · UNKNOWN

Trial details

NCT number: NCT03507998
Sponsor: Curegenix Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma Gastric Adenocarcinoma Pancreatic Adenocarcinoma Bile Duct Carcinoma Hepatocellular Carcinoma Esophageal Carcinoma Gastrointestinal Cancer

Start date: 2017-06-17
Primary completion: 2021-04-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.